Ananda Pharma achieves key Phase 1 milestone for MRX1 CBD program

Daiichi Sankyo and AstraZeneca report positive phase 3 results for DATROWAY in metastatic triple negative breast cancer

Avobis Bio's AVB-114 implantable cell therapy granted US FDA RMAT designation for Crohn's perianal fistulas

Alto Neuroscience receives FDA Fast Track designation for ALTO-101

Calico Life Sciences' investigational treatment for ADPKD receives US FDA Fast Track Designation

Kye Pharmaceuticals' AGAMREE (vamorolone) approved in Canada to treat DMD

XenoSTART and Minerva Imaging expand partnership

Jazz Pharmaceuticals' Zepzelca (lurbinectedin) and atezolizumab (Tecentriq) combination approved by FDA in ES-SCLC

Pharming receives FDA priority review for leniolisib in children with APDS

Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m

Abbvie invests in US expansion

Ocular Therapeutix prices USD475m common stock offering

Orion's ODM-105 (tasipimidine) insomnia study fails to achieve primary goal

Merck's WINREVAIR reduces clinical worsening by 76% in early PAH patients

Vicore Pharma's buloxibutid receives orphan drug designation in Japan